SCHEMBL30808177

SCHEMBL30808177

Cc1cc(Br)c2nc(N3CCOCC3)cnc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 1/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ KMT2A Q03164 5/20 0.41
▸ MEN1 O00255 4/20 0.40
▸ CRHBP P24387 1/20 0.40
▸ CRHR2 Q13324 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ ALDH1A1 P00352 5/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ GAA P10253 3/20 0.40
▸ HPGD P15428 3/20 0.40
▸ CYP2C19 P33261 3/20 0.40
▸ MAPT P10636 3/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ CYP2C9 P11712 2/20 0.39
▸ HTT P42858 3/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ CYP11B1 P15538 1/20 0.38
▸ CYP11B2 P19099 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18739629 1.00 MET (0.47) METSMN1; SMN2KMT2AMEN1CRHBP
SCHEMBL18739631 0.89 ALDH1A1 (0.43) METSMN1; SMN2KMT2AMEN1CRHBP
SCHEMBL30808197 0.87 MET (0.50) METSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL30808192 0.87 MET (0.50) METSMN1; SMN2CRHBPCRHR2KDM4E
SCHEMBL30808201 0.86 MET (0.49) METSMN1; SMN2CRHBPCRHR2NPC1
SCHEMBL18739760 0.86 KMT2A (0.46) SMN1; SMN2KMT2AMEN1CRHBPCRHR2
SCHEMBL30808213 0.84 MET (0.46) METSMN1; SMN2KMT2AMEN1NPC1
SCHEMBL18739601 0.81 PIK3CA (0.45) SMN1; SMN2ALDH1A1KDM4EHPGDPIK3CD
SCHEMBL30808159 0.81 MET (0.49) MET
SCHEMBL30808207 0.80 MET (0.44) METSMN1; SMN2KMT2ACRHBPCRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026419-A1 QUINOXALINE DERIVATIVES AS PIK3 ALPHA MODULATORS BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback